Retatrutide Research: What the Triple-Agonist Data Actually Shows in 2026

Last updated: September 1, 2026 Research Use Only. This article discusses published preclinical and clinical-trial literature on retatrutide (LY3437943) for informational purposes. It does not describe, recommend, or imply any human use, dosing, or health outcome for any retatrutide research…



